gefitinib has been researched along with zerumbone in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (zerumbone) | Trials (zerumbone) | Recent Studies (post-2010) (zerumbone) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 194 | 0 | 149 |
| Protein | Taxonomy | gefitinib (IC50) | zerumbone (IC50) |
|---|---|---|---|
| Zinc finger protein GLI1 | Homo sapiens (human) | 7.1 | |
| Zinc finger protein GLI2 | Homo sapiens (human) | 0.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, R; Li, DL; Wang, JG; Yan, MJ | 1 |
1 other study(ies) available for gefitinib and zerumbone
| Article | Year |
|---|---|
Zerumbone combined with gefitinib alleviates lung cancer cell growth through the AKT/STAT3/SLC7A11 axis.
Topics: Amino Acid Transport System y+; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor | 2023 |